Robert Musterer | 07/19/2016
It is well known that pharmaceutical companies have almost a bizarre mixture of units in which some are on cutting edge of science and technologies while other units are extremely slow to adopt and utilize new solutions. This slow pace is particularly prevalent in the support of clinical trials. Companies have been historically slow to adopt new technologies, a prime example being Electronic Data Capture. First commercial systems became available in the 1980’s and widespread adoption really did...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More